etoposide has been researched along with 9,10-dimethyl-1,2-benzanthracene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WJ; Chou, HY; Li, TK; Shen, TL; Tai, PH; Yang, YC | 1 |
| Choi, HG; Kim, SH; Lee, MG; Lim, SJ; Yang, SH | 1 |
2 other study(ies) available for etoposide and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Line; Cell Transformation, Neoplastic; Coculture Techniques; DNA Cleavage; DNA Topoisomerases, Type II; Etoposide; HCT116 Cells; HL-60 Cells; Humans; Inflammation; Mice; Mice, Knockout; Mutagenesis; Nitric Oxide; Nitric Oxide Donors; Pyridines; S-Nitrosoglutathione | 2013 |
Effects of morin on the pharmacokinetics of etoposide in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in female Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Cytochrome P-450 CYP3A; Drug Screening Assays, Antitumor; Etoposide; Female; Flavonoids; Gene Expression; Liver; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2013 |